New contact lens delivers glaucoma drug; Mass vaccination inhaler could be used in natural disasters; Pediatric leukemia drug delivered with less pain;

> A contact lens designed by researchers at Harvard Medical School, Boston Children's Hospital and MIT has a thin layer of latanaprost, which is the most common drug used to treat glaucoma and could be better at delivering the drug than eyedrops. Article

> Cambridge, U.K.-based Team Consulting designed a mass vaccination technology that administers vaccines via an inhaler. The low-cost Occoris inhaler could help vaccinate people in areas hit by natural disasters, according to a Business Weekly article.

> A pediatric leukemia chemotherapy drug long administered via painful intramuscular injection may now be safely administered via IV infusion due to a reformulation. Story

> Battelle and Zogenix ($ZGNX) have renewed an agreement to co-market Zogenix's drug delivery system designed for self-injection of biologic therapies. More

> Adocia signed an exclusive lisence agreement with the CNRS, the University Bordeaux I, the Institut Polytechnique de Bordeaux and Aquitaine Science Transfert, granting Adocia protection of its nanotech-based cancer drug delivery system. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.